Assessment of the Surveillance Interval at 1 Year after Curative Treatment in Hepatocellular Carcinoma: Risk Stratification

BACKGROUND/AIMS: Guidelines recommend surveillance for hepatocellular carcinoma (HCC) recurrence at 3-month intervals during the first year after curative treatment and 6-month intervals thereafter in all patients. This strategy does not reflect individual risk of recurrence. We aimed to stratify ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Minjong, Chang, Young, Oh, Sohee, Cho, Young Youn, Jung, Dhong-Eun, Kim, Hong Hyun, Nam, Joon Yeul, Cho, Hyeki, Cho, Eun Ju, Lee, Jeong-Hoon, Yu, Su Jong, Yi, Nam-Joon, Lee, Kwang-Woong, Lee, Dong Ho, Lee, Jeong Min, Yoon, Jung-Hwan, Suh, Kyung-Suk, Kim, Yoon Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143446/
https://www.ncbi.nlm.nih.gov/pubmed/29730905
http://dx.doi.org/10.5009/gnl17365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143446/
https://www.ncbi.nlm.nih.gov/pubmed/29730905
http://dx.doi.org/10.5009/gnl17365

Ejemplares similares